December 26, 2024 - 12:03

TSMC’s 2nm technology is not expected to be adopted by Apple’s iPhones before 2026 due to an incredibly low monthly production wafer count. This delay comes as Apple continues to evaluate its supply chain and production capabilities. The anticipated rollout of this advanced technology was initially expected to enhance the performance and efficiency of future iPhone models. However, the current production limitations have prompted Apple to reconsider its timeline.
Industry experts suggest that TSMC is working diligently to ramp up its manufacturing capacity, with projections indicating that wafer capacity could increase by as much as eight times by 2026. This increase could potentially allow Apple to incorporate the cutting-edge technology into its devices, offering significant improvements in processing power and energy efficiency. Until then, Apple will likely continue utilizing existing chip technologies to meet consumer demands and maintain its competitive edge in the smartphone market.
August 8, 2026 - 01:15
19th century real estate agents used ‘peepshow’ technology to sell glitzy mansionBefore Zillow, before glossy real estate brochures, there was the cosmorama. In the 1840s, wealthy home sellers and developers in Europe and America turned to these handheld viewing boxes to show...
August 7, 2026 - 06:56
AI used to create viruses not found in nature for first timeA team of researchers in the United States has announced the creation of 16 new viruses that do not exist in nature, marking the first time artificial intelligence has been used to design such...
August 6, 2026 - 19:49
MatSing Details Manufacturing Technology to Improve Satellite Antenna PerformanceMatSing has introduced a proprietary manufacturing process designed to boost the capabilities of multibeam and wideband antennas used in satellite communications. The company says the new technique...
August 6, 2026 - 03:31
FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe U.S. Food and Drug Administration has given the green light to Moderna`s new influenza vaccine, marking the first time a flu shot built on messenger RNA technology has been licensed. The...